New agent joins hydroxyurea as FDA-approved sickle cell treatment
AAP News 2016;387:661-670) found that HU and phlebotomy for iron overload may be an acceptable alternative to chronic transfusion therapy and iron chelation for primary stroke prevention in certain children with abnormal TCDs. Any physician can prescribe HU ... |
from phlebotomy - Google News http://bit.ly/2OPNHoa
No comments:
Post a Comment